Long-COVID Care


Schedule Telemedicine Appointment



There is growing evidence that coronavirus disease 2019 (COVID-19) can lead to a dysregulation of the immune system with the development of autoimmune phenomena that can explain any of the symptoms associated with Long COVID. The consequence of this immune system dysregulation ranges from the production of autoantibodies to the development of new-onset Auto-immune & Auto-inflammatory diseases.  

The diseases reported more frequently were vasculitis and inflammatory arthritis. Idiopathic inflammatory myopathies, antiphospholipid syndrome, autoimmune cytopenias, hemophagocytic lymphohistiocytosis/Macrophage Activation Syndrome (MAS), systemic lupus erythematosus, and sarcoidosis were also reported in a limited number of patients, as well as isolated cases of systemic sclerosis and adult-onset Still’s disease.

Experiencing post-COVID conditions can be confusing and frustrating, and a person who feels sick long-term may feel isolated. Everyone experiences these conditions differently and may need different types of support, clinical investigation, and treatment.

Our practice offers comprehensive expert care for patients who are suffering from long-covid syndrome and/or have experienced new onset Autoimmune or Autoinflammatory disease as a sequela of a prior exposure to COVID-19.


Office Hygiene

  • To maintain social distancing within your facility, all patients sit at least six feet or more apart. We schedule infrequent patient appointments in order to minimize the number of patients in the waiting room to 0-2. We routinely disinfect the waiting are and the exam rooms throughout the day. Patients are asked to wear face masks.
  • We evaluate patients on a case-by-case basis. If presenting symptoms, travel history, and/or contacts are suspicious we ask the patient to schedule a telemedicine visit instead of coming to the office.
  • We constantly evaluate the physicians and the office staff for current or prior exposure. Our staff undergoes frequent PCR testing for Covid-19.